Inhibitory Effects of YP 12, A Newly Synthesized Obovatol Derivative on Rat Aortic Vascular Smooth Muscle Cell Proliferation |
Lim, Yong
(Department of Clinical Laboratory Science, Dong-eui Univerisity)
Lee, Mi-Yea (Department of Social Welfare, World Cyber College) Jung, Jae-Kyung (College of Pharmacy, Chungbuk National University) Pyo, Myoung-Yun (College of Pharmacy, Sookmyung Women's University) Yun, Yeo-Pyo (College of Pharmacy, Chungbuk National University) |
1 | Jung, F., Haendeler, J., Goebel, C., Zeiher, A. M., & Dimmeler, S. (2000). Growth factor-induced phosphoinositide 3-OH kinase/ Akt phosphorylation in smooth muscle cells: induction of cell proliferation and inhibition of cell death. Cardiovasc Res, 48(1), 148-157. DOI ScienceOn |
2 | Lee, M. S., Yang, J. E., Choi, E. H., In, J. K., Lee, S. Y., Lee, H., et al. (2007). Synthesis of obovatol derivatives and their preliminary evaluation as antitumor agents. Bull Korean Chem Soc, 28(9), 1601-1604. DOI |
3 | Lee, S. K., Kim, H. N., Kang, Y. R., Lee, C. W., Kim, H. M., Han, D. C., et al. (2008). Obovatol inhibits colorectal cancer growth by inhibiting tumor cell proliferation and inducing apoptosis. Bioorg Med Chem, 16(18), 8397-8402. DOI ScienceOn |
4 | Lim, Y., Kwon, J. S., Kim, D. W., Lee, S. H., Park, R. K., Lee, J. J., et al. (2010). Obovatol from Magnolia obovata inhibits vascular smooth muscle cell proliferation and intimal hyperplasia by inducing p21Cip1. Atherosclerosis, 210(2), 372-380. DOI ScienceOn |
5 | Majesky, M. W., Reidy, M. A., Bowen-Pope, D. F., Hart, C. E., Wilcox, J. N., & Schwartz, S. M. (1990). PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol, 111(5 Pt 1), 2149-2158. |
6 | Mulvany, M. J. (1990). Structure and function of small arteries in hypertension. J Hypertens Suppl, 8(7), S225-232. |
7 | Ross, R. (1990). Mechanisms of atherosclerosis--a review. Adv Nephrol Necker Hosp, 19, 79-86. |
8 | Ross, R. (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature, 362(6423), 801-809. DOI ScienceOn |
9 | Ross, R. (1995). Cell biology of atherosclerosis. Annu Rev Physiol, 57, 791-804. DOI ScienceOn |
10 | Ross, R. (1999). Atherosclerosis--an inflammatory disease. N Engl J Med, 340(2), 115-126. DOI ScienceOn |
11 | Bornfeldt, K. E., Raines, E. W., Graves, L. M., Skinner, M. P., Krebs, E. G., & Ross, R. (1995). Platelet-derived growth factor. Distinct signal transduction pathways associated with migration versus proliferation. Ann N Y Acad Sci, 766, 416-430. DOI |
12 | Braun-Dullaeus, R. C., Mann, M. J., & Dzau, V. J. (1998). Cell cycle progression: new therapeutic target for vascular proliferative disease. Circulation, 98(1), 82-89. DOI ScienceOn |
13 | Erlinge, D. (1998). Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol, 31(1), 1-8. DOI ScienceOn |
14 | Chamley, J. H., Campbell, G. R., McConnell, J. D., & Groschel- Stewart, U. (1977). Comparison of vascular smooth muscle cells from adult human, monkey and rabbit in primary culture and in subculture. Cell Tissue Res, 177(4), 503-522. |
15 | Claesson-Welsh, L. (1994). Platelet-derived growth factor receptor signals. J Biol Chem, 269(51), 32023-32026. |
16 | Dzau, V. J., Braun-Dullaeus, R. C., & Sedding, D. G. (2002). Vascular proliferation and atherosclerosis: new perspectives and therapeutic strategies. Nat Med, 8(11), 1249-1256. DOI ScienceOn |
17 | Fang, F., & Newport, J. W. (1991). Evidence that the G1-S and G2-M transitions are controlled by different cdc2 proteins in higher eukaryotes. Cell, 66(4), 731-742. DOI ScienceOn |
18 | Stroobant, P., & Waterfield, M. D. (1984). Purification and properties of porcine platelet-derived growth factor. EMBO J, 3(12), 2963-2967. |
19 | Sachinidis, A., Locher, R., Vetter, W., Tatje, D., & Hoppe, J. (1990). Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem, 265(18), 10238-10243. |
![]() |